← Back to Search

Motivational Texting for Heart Attack Care

N/A
Recruiting
Led By Dennis Ko, MD
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Presentation or admission to Sunnybrook Hospital with diagnosis of Acute Coronary Syndrome (ACS)
Be older than 18 years old
Must not have
Inability to consent for study in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within one month, 3 months, and 12 months of hospital discharge

Summary

This trial will study if texting can help improve care for heart attack patients and reduce hospital readmissions.

Who is the study for?
This trial is for heart attack patients over 18 who were treated at Sunnybrook Hospital, have a cellphone with texting, and can read and respond to English texts. It's not for those who can't consent in English or lack SMS-capable phones.
What is being tested?
The TEACH pilot trial tests if motivational text messages after hospital discharge can improve care for heart attack patients. Participants are randomly assigned to receive these texts or be in a control group without them.
What are the potential side effects?
Since the intervention involves sending and receiving text messages, there are no direct medical side effects. However, participants may experience stress or anxiety from regular communication about their health condition.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was admitted to Sunnybrook Hospital with a heart attack or related condition.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot give consent in English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within one month, 3 months, and 12 months of randomization
This trial's timeline: 3 weeks for screening, Varies for treatment, and within one month, 3 months, and 12 months of randomization for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Physician visit
Secondary study objectives
Emergency Department presentation
Medication compliance
Re-hospitalization

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Texting intervention groupExperimental Treatment1 Intervention
Subjects will receive specific health-related texts
Group II: Control groupPlacebo Group1 Intervention
Subjects will receive general text messages without health information

Find a Location

Who is running the clinical trial?

Sunnybrook Health Sciences CentreLead Sponsor
674 Previous Clinical Trials
1,565,239 Total Patients Enrolled
11 Trials studying Coronary Artery Disease
3,947 Patients Enrolled for Coronary Artery Disease
Dennis Ko, MDPrincipal InvestigatorResearch Director

Media Library

Motivational texting Clinical Trial Eligibility Overview. Trial Name: NCT05628337 — N/A
Coronary Artery Disease Research Study Groups: Control group, Texting intervention group
Coronary Artery Disease Clinical Trial 2023: Motivational texting Highlights & Side Effects. Trial Name: NCT05628337 — N/A
Motivational texting 2023 Treatment Timeline for Medical Study. Trial Name: NCT05628337 — N/A
~73 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top